Trial intelligence / Profile preview

Tramadol as adjunct to ropivacaine in shoulder surgery

NCT02182752Phase 2Completed

Sponsor
Asklepieion Voulas General Hospital
Start
Apr 2013
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of tramadol in postoperative pain (2 arms), sponsored by Asklepieion Voulas General Hospital. Primary endpoint: Postoperative analgesia at 24 hours. Started Apr 2013; status: completed.

02

Drugs

tramadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02182752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02182752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call